Matthew L. Posard

Director

Matthew L. Posard (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $2.0M of HALO (18,996 sh across 4 lots, as filed), executed Sep 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.0M

shares × price, as filed

Last traded

Sep 16

Filed Sep 17

Median ADV $214.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

HALO

Halozyme Therapeutics, Inc. HALO · 0 buys · 1 sell 1 filing

Recent filings

HALOSALE Halozyme Therapeutics, Inc. View filing → $2.0M
18,996 sh across 4 lots
Exec Sep 16
Filed Sep 17 · 5:19 PM ET